Welltower (HCN) to Release Quarterly Earnings on Thursday

Welltower (NYSE:HCN) is scheduled to issue its quarterly earnings data before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of $0.47 per share for the quarter.

Welltower (HCN) opened at $54.15 on Thursday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.79. The firm has a market capitalization of $20,050.00, a PE ratio of 47.50, a PEG ratio of 3.79 and a beta of 0.17. Welltower has a 52-week low of $53.00 and a 52-week high of $78.17.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 21st. Stockholders of record on Tuesday, February 13th will be given a dividend of $0.87 per share. The ex-dividend date is Monday, February 12th. This represents a $3.48 annualized dividend and a dividend yield of 6.43%. Welltower’s dividend payout ratio is currently 305.26%.

In other Welltower news, Director Gary Whitelaw acquired 1,420 shares of the business’s stock in a transaction dated Tuesday, November 21st. The stock was bought at an average cost of $68.39 per share, with a total value of $97,113.80. Following the completion of the transaction, the director now directly owns 1,420 shares in the company, valued at approximately $97,113.80. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 0.19% of the company’s stock.

Several research analysts recently commented on HCN shares. Capital One Financial raised Welltower from an “equal weight” rating to an “overweight” rating in a research report on Wednesday, November 8th. Stephens set a $70.00 price target on Welltower and gave the company a “buy” rating in a research report on Friday, January 12th. ValuEngine raised Welltower from a “hold” rating to a “buy” rating in a research report on Saturday, January 13th. BMO Capital Markets set a $57.00 price target on Welltower and gave the company a “sell” rating in a research report on Monday, January 15th. Finally, Stifel Nicolaus reduced their price target on Welltower from $75.00 to $74.00 and set a “buy” rating for the company in a research report on Friday, November 3rd. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $71.62.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/02/15/welltower-hcn-to-release-quarterly-earnings-on-thursday.html.

About Welltower

Welltower Inc invests with seniors housing operators, post-acute providers and health systems to fund real estate and infrastructure. The Company invests in seniors housing and healthcare real estate. It operates in three segments: triple-net, seniors housing operating and outpatient medical. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities, and outpatient medical properties.

Earnings History for Welltower (NYSE:HCN)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply